PHAS Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2022-10-25 | NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | 4,857,525 | S-Sale | D | 1,784,109 | 0.15 | 262,264.02 |
| 2022-05-23 | Burkhardt Glen | officer: SVP of Human Resources | 0 | S-Sale | D | 11,248 | 0.79 | 8,885.92 |
| 2022-05-20 | Arnold Susan Elizabeth | officer: SVP, Technical Operations | 41,236 | A-Award | A | 10,917 | 0.68 | 7,437.75 |
| 2022-05-20 | Sharp John P | officer: Chief Financial Officer | 65,767 | A-Award | A | 6,026 | 0.68 | 4,105.51 |
| 2022-05-20 | Birchall Jonathan | officer: Chief Commercial Officer | 20,000 | A-Award | A | 20,000 | 0.68 | 13,626.00 |
| 2022-05-20 | Hanson Kristopher | officer: SVP and General Counsel | 8,463 | A-Award | A | 4,831 | 0.68 | 3,291.36 |
| 2022-05-20 | Mow Jonathan P | director, officer: Chief Executive Officer | 132,502 | A-Award | A | 10,918 | 0.68 | 7,438.43 |
| 2022-05-20 | Burkhardt Glen | officer: SVP of Human Resources | 11,248 | A-Award | A | 11,248 | 0.68 | 7,663.26 |
| 2022-05-19 | Humphries William D. | director | 2,538 | A-Award | A | 2,538 | 0.00 | 0.00 |
| 2022-05-19 | Humphries William D. | director | 11,842 | A-Award | A | 11,842 | 0.84 | 9,969.78 |
| 2022-05-19 | Thorp Clay | director | 3,750 | A-Award | A | 3,750 | 0.00 | 0.00 |
| 2022-05-19 | Thorp Clay | director | 17,500 | A-Award | A | 17,500 | 0.84 | 14,733.25 |
| 2022-05-19 | Humphries William D. | director | 3,750 | A-Award | A | 3,750 | 0.00 | 0.00 |
| 2022-05-19 | Humphries William D. | director | 17,500 | A-Award | A | 17,500 | 0.84 | 14,733.25 |
| 2022-05-19 | van den Broek Richard | director | 3,750 | A-Award | A | 3,750 | 0.00 | 0.00 |
| 2022-05-19 | van den Broek Richard | director | 17,500 | A-Award | A | 17,500 | 0.84 | 14,733.25 |
| 2022-05-19 | HARRIGAN EDMUND | director | 3,750 | A-Award | A | 3,750 | 0.00 | 0.00 |
| 2022-05-19 | HARRIGAN EDMUND | director | 17,500 | A-Award | A | 17,500 | 0.84 | 14,733.25 |
| 2022-05-19 | Loewy Caroline M | director | 3,750 | A-Award | A | 3,750 | 0.00 | 0.00 |
| 2022-05-19 | Loewy Caroline M | director | 17,500 | A-Award | A | 17,500 | 0.84 | 14,733.25 |
| 2022-05-19 | Sapir Alex | director | 3,750 | A-Award | A | 3,750 | 0.00 | 0.00 |
| 2022-05-19 | Sapir Alex | director | 17,500 | A-Award | A | 17,500 | 0.84 | 14,733.25 |
| 2022-05-19 | Hutson Nancy J | director | 3,750 | A-Award | A | 3,750 | 0.00 | 0.00 |
| 2022-05-19 | Hutson Nancy J | director | 17,500 | A-Award | A | 17,500 | 0.84 | 14,733.25 |
| 2022-02-24 | Burkhardt Glen | officer: VP, Human Resources | 87,500 | A-Award | A | 87,500 | 1.13 | 98,875.00 |
| 2022-02-24 | Burkhardt Glen | officer: VP, Human Resources | 18,750 | A-Award | A | 18,750 | 0.00 | 0.00 |
| 2022-02-24 | Sharp John P | officer: Chief Financial Officer | 115,500 | A-Award | A | 115,500 | 1.13 | 130,515.00 |
| 2022-02-24 | Sharp John P | officer: Chief Financial Officer | 24,750 | A-Award | A | 24,750 | 0.00 | 0.00 |
| 2022-02-24 | Birchall Jonathan | officer: Chief Commercial Officer | 52,500 | A-Award | A | 52,500 | 1.13 | 59,325.00 |
| 2022-02-24 | Birchall Jonathan | officer: Chief Commercial Officer | 11,250 | A-Award | A | 11,250 | 0.00 | 0.00 |
| 2022-02-24 | Lee John Sang | officer: Chief Medical Officer | 115,500 | A-Award | A | 115,500 | 1.13 | 130,515.00 |
| 2022-02-24 | Lee John Sang | officer: Chief Medical Officer | 24,750 | A-Award | A | 24,750 | 0.00 | 0.00 |
| 2022-02-24 | Mow Jonathan P | director, officer: Chief Executive Officer | 385,000 | A-Award | A | 385,000 | 1.13 | 435,050.00 |
| 2022-02-24 | Mow Jonathan P | director, officer: Chief Executive Officer | 82,500 | A-Award | A | 82,500 | 0.00 | 0.00 |
| 2022-02-24 | Hanson Kristopher | officer: VP, Head of Legal | 87,500 | A-Award | A | 87,500 | 1.13 | 98,875.00 |
| 2022-02-24 | Hanson Kristopher | officer: VP, Head of Legal | 18,750 | A-Award | A | 18,750 | 0.00 | 0.00 |
| 2022-02-24 | Arnold Susan Elizabeth | officer: SVP, Technical Operations | 87,500 | A-Award | A | 87,500 | 1.13 | 98,875.00 |
| 2022-02-24 | Arnold Susan Elizabeth | officer: SVP, Technical Operations | 18,750 | A-Award | A | 18,750 | 0.00 | 0.00 |
| 2021-11-19 | Mow Jonathan P | director, officer: Chief Executive Officer | 172,473 | A-Award | A | 5,623 | 2.01 | 11,302.23 |
| 2021-11-19 | Arnold Susan Elizabeth | officer: SVP, Technical Operations | 30,319 | A-Award | A | 2,559 | 2.01 | 5,143.59 |
| 2021-11-19 | Sharp John P | officer: Chief Financial Officer | 59,741 | A-Award | A | 2,017 | 2.01 | 4,054.17 |
| 2021-11-19 | Burkhardt Glen | officer: VP, Human Resources | 0 | S-Sale | D | 5,766 | 2.37 | 13,665.42 |
| 2021-11-19 | Burkhardt Glen | officer: VP, Human Resources | 5,766 | A-Award | A | 5,766 | 2.01 | 11,589.66 |
| 2021-11-19 | Hanson Kristopher | officer: VP, Head of Legal | 3,632 | A-Award | A | 1,545 | 2.01 | 3,105.45 |
| 2021-11-08 | Birchall Jonathan | officer: Chief Commercial Officer | 250,000 | A-Award | A | 250,000 | 3.37 | 842,500.00 |
| 2021-11-08 | Hutson Nancy J | director | 0 | M-Exempt | D | 7,400 | 3.15 | 23,310.00 |
| 2021-11-08 | Hutson Nancy J | director | 7,400 | M-Exempt | D | 1,500 | 3.15 | 4,725.00 |
| 2021-11-08 | Hutson Nancy J | director | 2,256 | M-Exempt | D | 24,860 | 2.26 | 56,183.60 |
| 2021-11-08 | Hutson Nancy J | director | 33,760 | M-Exempt | A | 7,400 | 3.15 | 23,310.00 |
| 2021-11-05 | Hutson Nancy J | director | 26,360 | M-Exempt | A | 1,500 | 3.15 | 4,725.00 |
| 2021-11-05 | Hutson Nancy J | director | 24,860 | M-Exempt | A | 24,860 | 2.26 | 56,183.60 |
| 2021-11-03 | Sharp John P | officer: Chief Financial Officer | 90,582 | M-Exempt | D | 7,500 | 1.68 | 12,600.00 |
| 2021-11-03 | Sharp John P | officer: Chief Financial Officer | 57,724 | M-Exempt | A | 7,500 | 1.68 | 12,600.00 |
| 2021-11-03 | Mow Jonathan P | director, officer: Chief Executive Officer | 108,767 | M-Exempt | D | 20,000 | 1.24 | 24,800.00 |
| 2021-11-03 | Mow Jonathan P | director, officer: Chief Executive Officer | 166,850 | M-Exempt | A | 20,000 | 1.24 | 24,800.00 |
| 2021-09-14 | Humphries William D. | director | 28,000 | A-Award | A | 28,000 | 2.80 | 78,400.00 |
| 2021-08-27 | Mow Jonathan P | director, officer: Chief Executive Officer | 146,850 | M-Exempt | A | 20,000 | 1.24 | 24,800.00 |
| 2021-08-27 | Mow Jonathan P | director, officer: Chief Executive Officer | 128,767 | M-Exempt | D | 20,000 | 1.24 | 24,800.00 |
| 2021-08-18 | Hutson Nancy J | director | 4,000 | P-Purchase | A | 3,000 | 3.08 | 9,240.00 |
| 2021-08-18 | Thorp Clay | director | 32,943 | P-Purchase | A | 10,000 | 3.00 | 30,000.00 |
| 2021-08-03 | Sharp John P | officer: Chief Financial Officer | 50,224 | M-Exempt | A | 7,500 | 1.68 | 12,600.00 |
| 2021-08-03 | Sharp John P | officer: Chief Financial Officer | 98,082 | M-Exempt | D | 7,500 | 1.68 | 12,600.00 |
| 2021-08-03 | Sharp John P | officer: Chief Financial Officer | 50,224 | A-Award | A | 7,500 | 1.68 | 12,600.00 |
| 2021-07-12 | Arnold Susan Elizabeth | officer: VP, Preclinical and Chem | 27,760 | A-Award | A | 4,519 | 1.74 | 7,863.06 |
| 2021-07-12 | Arnold Susan Elizabeth | officer: VP, Preclinical and Chem | 27,760 | M-Exempt | A | 4,519 | 1.74 | 7,863.06 |
| 2021-07-12 | Arnold Susan Elizabeth | officer: VP, Preclinical and Chem | 0 | M-Exempt | D | 4,519 | 1.74 | 7,863.06 |
| 2021-06-03 | Klein Peter Justin | director | 14,000 | A-Award | A | 14,000 | 3.53 | 49,420.00 |
| 2021-06-03 | van den Broek Richard | director | 14,000 | A-Award | A | 14,000 | 3.53 | 49,420.00 |
| 2021-06-03 | Hutson Nancy J | director | 14,000 | A-Award | A | 14,000 | 3.53 | 49,420.00 |
| 2021-06-03 | Loewy Caroline M | director | 14,000 | A-Award | A | 14,000 | 3.53 | 49,420.00 |
| 2021-06-03 | Thorp Clay | director | 14,000 | A-Award | A | 14,000 | 3.53 | 49,420.00 |
| 2021-06-03 | HARRIGAN EDMUND | director | 14,000 | A-Award | A | 14,000 | 3.53 | 49,420.00 |
| 2021-06-03 | Sapir Alex | director | 14,000 | A-Award | A | 14,000 | 3.53 | 49,420.00 |
| 2021-05-20 | Sharp John P | officer: Chief Financial Officer | 42,724 | A-Award | A | 1,419 | 2.80 | 3,973.20 |
| 2021-05-20 | Burkhardt Glen | officer: VP, Human Resources | 3,811 | A-Award | A | 3,811 | 3.29 | 12,538.19 |
| 2021-05-20 | Burkhardt Glen | officer: VP, Human Resources | 0 | S-Sale | D | 3,811 | 3.29 | 12,538.19 |
| 2021-05-20 | Hanson Kristopher | officer: VP, Head of Legal | 2,087 | A-Award | A | 1,088 | 2.80 | 3,046.40 |
| 2021-05-20 | Arnold Susan Elizabeth | officer: VP, Preclinical and Chem | 23,241 | A-Award | A | 5,257 | 2.80 | 14,719.60 |
| 2021-05-20 | York Michael | officer: VP, Corporate Development | 7,059 | A-Award | A | 2,897 | 2.80 | 8,111.60 |
| 2021-05-20 | Mow Jonathan P | director, officer: Chief Executive Officer | 126,850 | A-Award | A | 3,964 | 2.80 | 11,099.20 |
| 2021-02-05 | Arnold Susan Elizabeth | officer: VP, Preclinical and Chem | 36,000 | A-Award | A | 36,000 | 4.31 | 155,160.00 |
| 2021-02-05 | Lee John Sang | officer: Chief Medical Officer | 76,500 | A-Award | A | 76,500 | 4.31 | 329,715.00 |
| 2021-02-05 | Sharp John P | officer: Chief Financial Officer | 76,500 | A-Award | A | 76,500 | 4.31 | 329,715.00 |
| 2021-02-05 | York Michael | officer: VP, Corporate Development | 36,000 | A-Award | A | 36,000 | 4.31 | 155,160.00 |
| 2021-02-05 | Hanson Kristopher | officer: VP, Head of Legal | 36,000 | A-Award | A | 36,000 | 4.31 | 155,160.00 |
| 2021-02-05 | Mow Jonathan P | director, officer: Chief Executive Officer | 234,000 | A-Award | A | 234,000 | 4.31 | 1,008,540.00 |
| 2021-02-05 | Burkhardt Glen | officer: VP, Human Resources | 36,000 | A-Award | A | 36,000 | 4.31 | 155,160.00 |
| 2020-12-03 | HARRIGAN EDMUND | director | 6,000 | P-Purchase | A | 6,000 | 4.12 | 24,720.00 |
| 2020-11-24 | Thorp Clay | director | 22,943 | P-Purchase | A | 2,000 | 3.50 | 7,000.00 |
| 2020-11-23 | Thorp Clay | director | 20,943 | P-Purchase | A | 3,000 | 3.67 | 11,010.00 |
| 2020-11-23 | Burkhardt Glen | officer: VP, Human Resources | 0 | S-Sale | D | 3,497 | 3.45 | 12,064.65 |
| 2020-11-20 | Mow Jonathan P | director, officer: Chief Executive Officer | 122,886 | A-Award | A | 3,643 | 3.00 | 10,929.00 |
| 2020-11-20 | Arnold Susan Elizabeth | officer: VP, Preclinical and Chem | 17,984 | A-Award | A | 4,832 | 3.00 | 14,496.00 |
| 2020-11-20 | Ballance David James | officer: VP, Research and Sci. Affairs | 8,519 | A-Award | A | 919 | 3.00 | 2,757.00 |
| 2020-11-20 | York Michael | officer: VP, Corporate Development | 4,162 | A-Award | A | 2,662 | 3.00 | 7,986.00 |
| 2020-11-20 | Hanson Kristopher | officer: VP, Head of Legal | 999 | A-Award | A | 999 | 3.00 | 2,997.00 |
| 2020-11-20 | Sharp John P | officer: Chief Financial Officer | 41,305 | A-Award | A | 1,305 | 3.00 | 3,915.00 |
| 2020-11-20 | Burkhardt Glen | officer: VP, Human Resources | 3,497 | A-Award | A | 3,497 | 3.45 | 12,064.65 |
| 2020-11-16 | Thorp Clay | director | 0 | J-Other | D | 52,397 | 0.00 | 0.00 |
| 2020-11-16 | Thorp Clay | director | 17,943 | J-Other | A | 2,144 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.